Bioactive protein fraction DLBS1033 containing lumbrokinase isolated from Lumbricus rubellus: ex vivo, in vivo, and pharmaceutic studies

References

• Trisina J Sunardi F Suhartono MT Tjandrawinata RR DLBS1033, a protein extract from Lumbricus rubellus, possesses antithrombotic and thrombolytic activities J Biomed Biotechnol 2011 2011 519652 21403877
   PubMedGoogle Scholar
• Fan Q Wu C Li L Some features of intestinal absorption of intact fibrinolytic enzyme III-1 from Lumbricus rubellus Biochim Biophys Acta 2001 1526 3 286 292 11410338
   PubMed Web of Science ®Google Scholar
• Sukandar EY Anggadireja K Sigit JI Adnyana IK Tjandrawinata RR Toxicity studies of a bioactive protein with antithrombotic-thrombolytic activity, DLBS1033 Drug Chem Toxicol 2014 37 1 8 16 23834224
   PubMed Web of Science ®Google Scholar
• Tjandrawinata RR Arifin PF Tandrasasmita OM Rahmi D Aripin A DLBS1425, a Phaleria macrocarpa (Scheff.) Boerl. extract confers anti proliferative and proapoptosis effects via eicosanoid pathway J Exp Ther Oncol 2010 8 3 187 201 20734918
   PubMedGoogle Scholar
• Tjandrawinata RR Suastika K Nofiarny D DLBS3233 extract, a novel insulin sensitizer with negligible risk of hypoglycemia: A phase-I study Int J Diabetes and Metab 2012 21 13 20
   Google Scholar
• Shaji J Patole V Protein and peptide drug delivery: oral approaches Indian J Pharm Sci 2008 70 3 269 277 20046732
   PubMed Web of Science ®Google Scholar
• Huyghebaert N Vermeire A Neirynck S Steidler L Remaut E Remon JP Development of an enteric-coated formulation containing freeze-dried, viable recombinant Lactococcus lactis for the ileal mucosal delivery of human interleukin-10 Eur J Pharm Biopharm 2005 60 3 349 359 15927456
   PubMed Web of Science ®Google Scholar
• Shastri PN Ubale RV D’Souza MJ Implementation of mixture design for formulation of albumin containing enteric-coated spray-dried microparticles Drug Dev Ind Pharm 2013 39 2 164 175 22591196
   PubMed Web of Science ®Google Scholar
• Hashmat D Shoaib MH Mehmood ZA Bushra R Yousuf RI Lakhani F Development of enteric coated flurbiprofen tablets using Opadry/Acryl-Eze system – a technical note AAPS PharmSciTech 2008 9 1 116 121 18446471
   PubMed Web of Science ®Google Scholar
• Porter SC Coating of pharmaceutical dosage forms Troy DB Remington: The Science and Practice of Pharmacy 21st ed Baltimore, MD Lippincott Williams & Wilkins 2006 929 938
   Google Scholar
• Guo HX Heinämäki J Yliruusi J Diffusion of a freely water-soluble drug in aqueous enteric-coated pellets AAPS PharmSciTech 2002 3 2 E16 12916953
   PubMedGoogle Scholar
• The United States Pharmacoppia 31st ed United States Pharmacopoeia convention, Inc. Rockville 2008
   Google Scholar
• Prusty AK Sahu SK Biodegradable nanoparticles – a novel approach for oral administration of biological products International Journal of Pharmaceutical Sciences and Nanotechnology 2009 2 2 503 508
   Google Scholar
• Mustata G Dinh SM Approaches to oral drug delivery for challenging molecules Crit Rev Ther Drug Carrier Syst 2006 23 2 111 135 16952274
   PubMed Web of Science ®Google Scholar
• Mahato RI Narang AS Thoma L Miller DD Emerging trends in oral delivery of peptide and protein drugs Crit Rev Ther Drug Carrier Syst 2003 20 2–3 153 214 14584523
   PubMed Web of Science ®Google Scholar
• Hamman JH Enslin GM Kotzé AF Oral delivery of peptide drugs: barriers and developments BioDrugs 2005 19 3 165 177 15984901
   PubMed Web of Science ®Google Scholar
• Yan XM Kim CH Lee CK Shin JS Cho IH Sohn UD Intestinal absorption of fibrinolytic and proteolytic lumbrokinase extracted from earthworm, Eisenia andrei Korean J Physiol Pharmacol 2010 14 2 71 75 20473377
   PubMed Web of Science ®Google Scholar
• Yu Q Li P Yang Q Improving the absorption of earthworm fibrinolytic enzymes with mucosal enhancers Pharm Biol 2010 48 7 816 821 20645782
   PubMed Web of Science ®Google Scholar
• Cheng MB Wang JC Li YH Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme J Control Release 2008 129 1 41 48 18474405
   PubMed Web of Science ®Google Scholar
• Wu XC Ye R Duan Y Wong SL Engineering of plasmin-resistant forms of streptokinase and their production in Bacillus subtilis: streptokinase with longer functional half-life Appl Environ Microbiol 1998 64 3 824 829 9501422
   PubMed Web of Science ®Google Scholar
• Martignoni M Groothuis GM de Kanter R Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction Expert Opin Drug Metab Toxicol 2006 2 6 875 894 17125407
   PubMed Web of Science ®Google Scholar
• Sarver JG White D Erhardt P Bachmann K Estimating xenobiotic half-lives in humans from rat data: influence of log P Environ Health Perspect 1997 105 11 1204 1209 9370523
   PubMed Web of Science ®Google Scholar
• Snejdrova E Dittrich M Pharmaceutical applications of plasticized polymers Luqman M Recent Advances in Plasticizers Rijeka InTechopen.com 2012 69 82 Available from: http://www.intechopen.com/books/recent-advances-in-plasticizers/pharmaceutical-applications-of-plasticized-polymers Accessed June 23, 2014
   Google Scholar
• Lee BJ Pharmaceutical preformulation: physicochemical properties of excipients and powders and tablet characterization Cox Gad S Pharmaceutical Manufacturing Handbook: Production and Processes Hoboken, NJ John Wiley & Sons, Inc. 2007 879 931
   Google Scholar
• Chandler WL Alessi MC Aillaud MF Henderson P Vague P Juhan-Vague I Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels Circulation 1997 96 3 761 768 9264480
   PubMed Web of Science ®Google Scholar
• Köhler M Sen S Miyashita C Half-life of single-chain urokinase-type plasminogen activator (scu-PA) and two-chain urokinase-type plasminogen activator (tcu-PA) in patients with acute myocardial infarction Thromb Res 1991 62 1–2 75 81 1906642
   PubMed Web of Science ®Google Scholar
• Vugmeyster Y Xu X Theil FP Khawli LA Leach MW Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges World J Biol Chem 2012 3 4 73 92 22558487
   PubMedGoogle Scholar
• Wu C Li L Zhao J Fan Q Tian WX He RQ Effect of alpha2M on earthworm fibrinolytic enzyme III-1 from Lumbricus rubellus Int J Biol Macromol 2002 31 1–3 71 77 12559429
   PubMed Web of Science ®Google Scholar